Sepsis Care Enters a New Era as Surviving Sepsis Campaign Looks Beyond Survival

For more than two decades, the Surviving Sepsis Campaign has stood as the world’s most influential effort to tame one of medicine’s deadliest conditions. Launched in 2002, the campaign has produced successive editions of evidence-based guidelines that reshaped how hospitals recognize and treat sepsis and septic shock, driving early detection, standardizing care bundles, reducing healthcare costs and, above all, pushing survival rates upward. The most recent update, published in 2026 in the journal Intensive Care Medicine, continues that tradition. Yet a new editorial from leading intensivists Jozef Kesecioglu, Victoria Metaxa and Elie Azoulay argues that the campaign now faces a profound turning point: as more patients survive sepsis, the central question is no longer simply whether they live, but how they live, and whether the care they receive aligns with the outcomes that matter most to them and their families.

The scale of the problem remains staggering. Sepsis, the life-threatening organ dysfunction caused by a dysregulated host response to infection, continues to rank among the leading causes of death worldwide, accounting for millions of deaths each year despite major advances in recognition and management. Global estimates of hospital-treated sepsis underscore the enormous incidence and mortality burden, and the economic consequences extend far beyond the acute hospital stay. Survivors frequently require prolonged rehabilitation, recurrent healthcare use and long-term nursing support, and many lose their independence entirely. Epidemiological studies from Germany, for example, have documented the substantial costs and care dependency that follow sepsis hospitalization, painting a picture of a condition whose true burden is measured in years, not days.

Crucially, mortality statistics capture only part of that burden. A growing body of evidence shows that increasing numbers of sepsis survivors experience persistent cognitive impairment, physical disability, psychological distress and markedly reduced quality of life. Landmark follow-up studies of patients who survived acute respiratory distress syndrome, a condition closely intertwined with sepsis in the intensive care unit, revealed functional disability persisting five years after critical illness, while systematic reviews have shown that many critical illness survivors struggle to return to employment, with lasting psychosocial consequences. These findings suggest that success in sepsis care should be measured not only by survival but by the quality and meaning of that survival for patients and their families, including the often-overlooked burden carried by caregivers, who face psychological, physical, social and financial challenges of their own.

The editorial also emphasizes a clinical reality that is frequently obscured by the language of emergency medicine: sepsis is not always an isolated and reversible disease process. For some patients, it represents a transient physiological insult from which meaningful recovery is expected. For others, it may be the final manifestation of advanced malignancy, severe frailty, end-stage organ failure or another life-limiting condition. In such situations, aggressive organ support and life-sustaining therapies may prolong life without achieving outcomes that patients would consider acceptable. Recognizing this heterogeneity, the authors argue, is essential when defining treatment goals and evaluating whether ongoing interventions remain appropriate. A one-size-fits-all approach that maximizes physiological parameters in every patient risks delivering care that is technically successful but profoundly misaligned with individual values.

To address this, the authors propose viewing sepsis and septic shock as a trajectory rather than a single event. During the acute phase, which generally covers the first several hours after recognition and extends through the first 24 to 72 hours, survival remains the primary objective. Early recognition, rapid diagnosis and prompt initiation of evidence-based therapies are essential, and the campaign’s guidelines have extensively addressed this phase over the last 25 years. Patients and families should be involved in decision-making whenever possible, even though this is often difficult during the initial stages of critical illness, when both families and clinicians typically prioritize survival. Still, the editorial stresses that even in the acute phase clinicians should consider whether initiating life-sustaining treatment is consistent with the patient’s wishes and values, a point of particular ethical weight because not starting treatment is often perceived as less difficult than withdrawing it later.

The acute phase is followed by a period of ongoing critical illness that may last for days or weeks, depending on the patient’s clinical course. During this stage, clinicians must reassess prognosis, treatment options and the balance between the burden of interventions and the likelihood of meaningful recovery. Patient goals and values should be revisited as clinical circumstances evolve, linking medical interventions to outcomes that are meaningful to patients rather than focusing solely on survival. The authors point to the concept of goal-directed health care, which redefines health and health care in the era of value-based medicine, and to consensus frameworks from other acute specialties, such as stroke, that have already embedded goal-concordant care into quality improvement standards. Such an approach, they argue, may strengthen therapeutic relationships, support shared decision-making and improve adherence to treatment plans.

Culture, communication and belief systems occupy a central place in this vision. Cultural identity encompasses not only ethnicity, language and religion but also family structures, values and beliefs about illness, death and healthcare itself. Care plans should address patients’ preferences, life goals and cultural context, and healthcare systems may need culturally specific resources to bridge communication gaps and support equitable care. The editorial cites the multinational ETHICATT study, which demonstrated that religion and religiosity significantly influence end-of-life decisions and patient autonomy in intensive care units across different countries, and in some settings religious beliefs may also shape the legal and ethical dimensions of end-of-life decision-making. Effective, structured communication is presented as fundamental throughout the entire course of sepsis, ensuring that patients and families are informed, heard and able to participate in decisions aligned with the patient’s goals and values.

Yet the evidence suggests this component of care remains underdeveloped. Research on sepsis hospitalizations has documented persistent deficits in the identification of patient goals and in the delivery of goal-concordant care after discharge. Prognostic uncertainty, time pressures and the traditional focus on physiological stabilization contribute to delayed conversations about treatment preferences. Policy statements from the American College of Critical Care Medicine and the American Thoracic Society have established shared decision-making as a standard in intensive care, and practical guidance on evidence-based ICU family conferences and the fine-tuning of family partnerships in decision-making provide clinicians with tested frameworks. Evidence also indicates that involving palliative care specialists can improve communication, facilitate decision-making and reduce potentially non-beneficial interventions without compromising quality of care, including for older adults hospitalized with septic shock. The editorial’s conclusion is unambiguous: communication should be considered a core component of high-quality sepsis management rather than an adjunct to it.

As patients enter the recovery phase, attention must shift toward functional outcomes, quality of life and psychological well-being, with comprehensive rehabilitation and follow-up programs recognized as essential components of recovery after sepsis. The authors acknowledge that the 2026 Surviving Sepsis Campaign guidelines have already moved in this direction, including Good Practice Statements in areas where high-certainty evidence is difficult to generate, and offering recommendations on goals-of-care discussions, advance directives, time-limited trials, palliative care and long-term outcomes. But they argue that future guidelines should go further, giving greater prominence to outcomes such as functional independence, cognitive performance, psychological well-being and caregiver burden. Where evidence is limited, recommendations may appropriately be informed by professional standards, ethical principles, patient values and societal goals, a stance the authors insist does not weaken evidence-based medicine but increases its transparency. The future of sepsis care, they conclude, lies not in departing from evidence-based medicine but in expanding it toward value-informed, goal-centred care, in which survival remains vital but is recognized as only one of several outcomes patients may value, alongside dignity, meaningful relationships, freedom from prolonged suffering and symptom control.

Subject of Research: Patient-centred, goal-concordant sepsis care within the Surviving Sepsis Campaign guidelines

Article Title: Surviving Sepsis Campaign beyond survival: aligning sepsis care with patient goals

Article References: Kesecioglu, J., Metaxa, V., & Azoulay, E. (2026). Surviving Sepsis Campaign beyond survival: aligning sepsis care with patient goals. Intensive Care Medicine. https://doi.org/10.1007/s00134-026-08590-4

Image Credits: AI Generated

DOI: 10.1007/s00134-026-08590-4

Keywords: sepsis, septic shock, Surviving Sepsis Campaign, intensive care, shared decision-making, palliative care, goals of care, patient-centred care, post-sepsis morbidity, critical illness recovery, end-of-life care, clinical guidelines